• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现代重复肝切除治疗复发性肝细胞癌后的不良预后因素。

Poor prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma in the modern era.

作者信息

Tsujita Eiji, Yamashita Yo-Ichi, Takeishi Kazuki, Matsuyama Ayumi, Tsutsui Shin-Ichi, Matsuda Hiroyuki, Toshima Takeo, Taketomi Akinobu, Shirabe Ken, Ishida Teruyoshi, Maehara Yoshihiko

机构信息

Department of Surgery, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.

出版信息

Am Surg. 2012 Apr;78(4):419-25.

PMID:22472398
Abstract

The purpose of this study was to determine the poor prognostic factors after repeat hepatectomy (Hx) in patients with recurrent hepatocellular carcinoma (HCC). Overall survival rates and clinicopathological variables in 112 patients with repeat Hx from 1992 to 2010 were compared with those in 531 patients who underwent a primary Hx. To clarify the poor prognosis factors after repeat Hx, survival data among 112 patients were univariately and multivariately analyzed. Overall survival after repeat Hx was similar for that of the patients who underwent a primary Hx. The mean age of repeat Hx group was significantly higher, and a well-preserved liver function was recognized than the primary Hx group. Multivariate analysis revealed that: 1) indocyanine green retention rate at 15 minutes; 2) disease-free interval; 3) tumor size; 4) portal vein invasion at primary Hx; 5) gender; and 6) estimated blood loss to be an independent and significant poor prognostic factors. The overall 3-year postrecurrence overall survival rates were 100, 91.3, 59.6, and 0 per cent at risk number (R) R0, R1/2, R3, R4, respectively (P < 0.05). Repeat Hx provided a good compatible prognosis with primary Hx. In our findings, five risk factors to predict poor outcomes after repeat Hx were useful. Patients with recurrent HCC do not have universally poor outcomes, and our simple scoring system using five poor prognostic factors could serve to advise the prognosis and the potential benefit for patient selection about repeat Hx.

摘要

本研究的目的是确定复发性肝细胞癌(HCC)患者再次肝切除术后的不良预后因素。将1992年至2010年112例行再次肝切除术患者的总生存率和临床病理变量与531例行初次肝切除术患者的进行比较。为明确再次肝切除术后的不良预后因素,对112例患者的生存数据进行单因素和多因素分析。再次肝切除术后的总生存率与初次肝切除术后相似。再次肝切除组的平均年龄显著更高,且肝功能保存情况优于初次肝切除组。多因素分析显示:1)15分钟吲哚菁绿滞留率;2)无病间期;3)肿瘤大小;4)初次肝切除时门静脉侵犯;5)性别;6)估计失血量是独立且显著的不良预后因素。复发后总体3年总生存率在风险数(R)为R0、R1/2、R3、R4时分别为100%、91.3%、59.6%和0%(P<0.05)。再次肝切除与初次肝切除的预后良好且相似。在我们的研究结果中,五个预测再次肝切除术后不良结局的风险因素很有用。复发性HCC患者并非普遍预后不良,我们使用五个不良预后因素的简单评分系统可用于指导预后以及为患者选择再次肝切除提供潜在获益建议。

相似文献

1
Poor prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma in the modern era.现代重复肝切除治疗复发性肝细胞癌后的不良预后因素。
Am Surg. 2012 Apr;78(4):419-25.
2
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者再次肝切除术的选择标准。
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.
3
Repeat hepatectomy for recurrent hepatocellular carcinoma.复发性肝细胞癌的再次肝切除术
Surgery. 2007 May;141(5):589-97. doi: 10.1016/j.surg.2006.12.014.
4
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
5
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.中国单中心经验:复发性肝细胞癌患者再次肝切除的长期结果及复发类型分析和其预后。
Ann Surg Oncol. 2012 Aug;19(8):2515-25. doi: 10.1245/s10434-012-2269-7. Epub 2012 Mar 7.
6
Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas.复发性肝细胞癌再次肝切除的疗效
ANZ J Surg. 2009 Oct;79(10):729-33. doi: 10.1111/j.1445-2197.2009.05059.x.
7
Repeat hepatectomy for recurrent hepatocellular carcinoma.复发性肝细胞癌的再次肝切除术
Surgery. 1994 Jun;115(6):703-6.
8
The Feasibility of Third or More Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma.复发性肝细胞癌第三次或更多次重复肝切除术的可行性
Ann Surg. 2015 Aug;262(2):347-57. doi: 10.1097/SLA.0000000000000882.
9
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients.肝细胞癌肝切除术后的长期预后:204例连续患者的生存分析
Cancer. 1998 Dec 1;83(11):2302-11.
10
Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.复发性肝细胞癌的二次肝切除实现了对丙型肝炎干扰素治疗的持续病毒学应答。
Hepatogastroenterology. 2013 Nov-Dec;60(128):2048-54. doi: 10.5754/hge13382.

引用本文的文献

1
Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy.肝切除术后复发性肝细胞癌根治性治疗策略预后的网状Meta分析
World J Gastrointest Surg. 2023 Feb 27;15(2):258-272. doi: 10.4240/wjgs.v15.i2.258.
2
Correlation between systemic immune inflammatory index and prognosis of patients with hepatic alveolar hydatid disease and establishment of a nomogram prediction model.肝泡型包虫病患者全身免疫炎症指标与预后的相关性及列线图预测模型的建立
Front Surg. 2023 Jan 6;9:1019963. doi: 10.3389/fsurg.2022.1019963. eCollection 2022.
3
Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.
肝切除术后复发性肝细胞癌的手术策略:当前证据综述
Cancers (Basel). 2023 Jan 13;15(2):508. doi: 10.3390/cancers15020508.
4
A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma.一种预测复发性肝细胞癌肝切除术后长期生存的新型列线图。
Front Oncol. 2021 Mar 25;11:646638. doi: 10.3389/fonc.2021.646638. eCollection 2021.
5
Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.孤立性可移植肝细胞癌的肝切除术:甲胎蛋白评分的作用
World J Surg. 2019 Jan;43(1):221-229. doi: 10.1007/s00268-018-4769-5.
6
Ultrasound-guided radiofrequency ablation enhances natural killer-mediated antitumor immunity against liver cancer.超声引导下射频消融增强自然杀伤细胞介导的抗肝癌免疫。
Oncol Lett. 2018 May;15(5):7014-7020. doi: 10.3892/ol.2018.8231. Epub 2018 Mar 12.
7
Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.脾体积和脾切除术对根治性肝切除术后符合米兰标准的肝细胞癌预后的影响
World J Surg. 2018 Apr;42(4):1120-1128. doi: 10.1007/s00268-017-4232-z.
8
Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma.肝切除术在复发性或初始不可切除肝细胞癌中的作用。
World J Hepatol. 2014 Dec 27;6(12):836-43. doi: 10.4254/wjh.v6.i12.836.
9
Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.肝移植时代肝细胞癌的肝切除术
World J Gastroenterol. 2014 Jul 28;20(28):9237-44. doi: 10.3748/wjg.v20.i28.9237.
10
Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities.肝细胞癌:长期生存的临床研究和治疗方式的选择。
World J Gastroenterol. 2013 Jun 21;19(23):3649-57. doi: 10.3748/wjg.v19.i23.3649.